Article
Two tyrosine residues in the first transmembrane helix of the human vasoactive intestinal peptide receptors play a role in supporting the active conformation.
British journal of pharmacology - 1 Aug 2002
Perret J, Vertongen P, Solano R M, Langer I, Cnudde J, Robberecht P, Waelbroeck M
Abstract excerpt
1: We investigated the human vasoactive intestinal polypeptide (VIP) receptors VPAC(1) and VPAC(2) mutated at conserved tyrosine residues in the first transmembrane helix (VPAC(1) receptor Y146A and Y150A and VPAC(2) receptor Y130A and Y134A). 2: [(125)I]-Acetyl-His(1) [D-Phe(2), K(15), R(16), L(27)]-VIP (1-7)/GRF (8-27) (referred to as [(125)I]-VPAC(1) antagonist) labelled VPAC(1) binding sites, that displayed...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
